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Sudden sensorineural hearing loss (SSNHL) is an important acute clinical condition in
children. A speciﬁc treatment is still missing. Hyperbaric oxygen (HBO) therapy is one of
the recommended treatments for SSNHL in adults. Our knowledge on the use of HBO
therapy in children for SSNHL is limited. Herein, we report the successful use of HBO
therapy in the management of SSNHL in a 14-year-old child.1. Introduction
Sudden sensorineural hearing loss (SSNHL) is character-
ized by a signiﬁcant hearing loss occurring within 72 h in at
least 3 consecutive audiogram frequencies. Although SSNHL
is less common in children than in adults, the prognosis is
worse[1,2].
Treatment of SSNHL in both adults and children is usually
challenging and a speciﬁc treatment for SSNHL is still missing.
Hyperbaric oxygen (HBO) therapy, which involves the inhala-
tion of oxygen (> 95%) at elevated atmospheric pressures inside
a pressurized chamber, is one of the promising treatments in the
management of SSNHL[3]. The majority of studies assessing the
efﬁcacy of HBO therapy on SSNHL have enrolled merely adult
patients, and hence our knowledge on the use of HBO in the
pediatric population is limited.Herein, we report the successful use of HBO therapy in the
management of SSNHL in a 14-year-old child.
2. Case report
A 14 year-old boy was brought to the Undersea and Hy-
perbaric Medicine Department for unilateral hearing loss, which
had started approximately 25 days ago and failed a course of
medical treatment.
The physical examination of external ear canal and ear drum
was unremarkable. Audiometric assessment revealed sensori-
neural hearing loss on the left ear (Figure 1).
Following written informed consent and education
regarding ear clearing, HBO therapy was scheduled to be
delivered once a day at 2.4 atmospheres absolute. Each HBO
session would involve three periods of 30 min oxygen inha-
lation interspersed with two periods of 5 min air inhalation.
The ﬁrst 6 HBO sessions went uneventful. On Day 7, the pa-
tient reported ﬂu like symptoms and otoscopic examination
revealed failure to ear clearance, a major risk factor for middle-
ear barotrauma. Medical treatment was prescribed and HBO
therapy was postponed for 3 days. Following medical man-
agement with a systemic decongestant, control otoscopicss article under the CC BY-NC-ND license (http://
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Figure 1. Pure tone audiometry of the patient before HBO therapy.
: Unmasked air conduction thresholds for the right ear; : Unmasked air
conduction thresholds for the left ear; : Masked air conduction thresholds
for the left ear; : Unmasked bone conduction thresholds for the right ear; :
Masked bone conduction thresholds for the left ear.
Murat Salihoglu et al./Journal of Acute Disease 2016; 5(4): 340–342 341examination revealed persistence in failure to ear clearance and
HBO therapy was postponed for 4 more days. After 7 days of
interruption, the patient was able to clear his ears and
completed a total of 20 HBO sessions. At the completion of
treatment, both the symptoms and the audiogram were signif-
icantly resolved (Figure 2). On follow up at 6 months, pure
tone audiometer revealed complete recovery (Figure 3).
Informed consent was obtained from patient and his parents to
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Figure 2. Pure tone audiometry of the patient after HBO therapy.
: Unmasked air conduction thresholds for the right ear; : Unmasked air
conduction thresholds for the left ear; : Masked air conduction thresholds
for the left ear; : Unmasked bone conduction thresholds for the right ear;
: Unmasked bone conduction thresholds for the left ear; : Masked bone
conduction thresholds for the left ear.
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Figure 3. Pure tone audiometry of the patient at 6 months follow-up.
: Unmasked air conduction thresholds for the right ear; : Unmasked air
conduction thresholds for the left ear; : Masked air conduction thresholds
for the left ear; : Unmasked bone conduction thresholds for the right ear;
: Unmasked bone conduction thresholds for the left ear.3. Discussion
SSNHL has a lower prevalence in children than in adults and
studies dealing with hearing loss in children are, therefore, rare.
Although some studies involve both pediatric and adult pa-
tients, they haven't speciﬁcally reported on the children's
characteristics and treatment outcomes[4]. Nevertheless, several
retrospective studies with small sample sizes are available.
Roman et al. performed a study on 12 children with SSNHL,
while total recovery was reported in 4 (28.5%) children,
partial recovery was reported in 4 (28.5%) and no recovery in
6 (43%) children[1]. Roman et al. also reported that severe
hearing loss, the presence of vertigo and a downward
audiometric curve were negative prognostic factors[1]. Inci
et al., conducted a study on 43 children and reported the
treatment failure in 23 of the 50 ears (46%)[5]. Treatment
delay and the presence of vertigo were negative prognostic
factors. Chen et al. reported complete recovery in 8 of 14
(57%) children with SSNHL and partial recovery in 5
(36%)[6]. A hearing loss greater than 50 dB was a poor
prognostic factor[6].
There is not a speciﬁc treatment for SSNHL in children.
Several treatment options with varying success rates have been
reported. Roman et al. used piracetam (50 mg/kg/day), meth-
ylprednisolone (1 mg/kg/day) and carbogen inhalation
(15 min/day)[1]. Chen et al. used prednisolone at an initial dose
of 3 mg/kg/day and tapering gradually[6]. Inci et al. used the
combination of HBO therapy and corticosteroids (1 mg/kg/
day)[5].
Herein, we report a child who received HBO therapy for
SSNHL, 25 days after the diagnosis. Data on the efﬁcacy of
HBO therapy in pediatric patients with SSNHL is limited.
Although our patient had several bad prognostic factors, such as
severe hearing loss (> 80 dB), failure to thrive medical treatment
and delayed HBO therapy, a signiﬁcant improvement in hearing
was achieved following HBO therapy and complete recovery
was observed at 6 months follow-up[1,5–7].
For more than two decades now, HBO therapy has been used
in the treatment of SSNHL. Impairment in circulation and a
resulting hypoxia in the inner ear organs is one of the most
popular theories on the pathophysiology of SSNHL. The ratio-
nale behind the use of HBO therapy in SSNHL, in this sense, is
the restoration of the oxygen tension in the inner ear to avoid
further damage to the cochlear tissue.
HBO therapy by the way of increasing the amount of ox-
ygen dissolved in plasma improves tissue perfusion and sus-
tains hypoxic cells in the endo- and peri-lymph[7]. While HBO
therapy is not yet accepted as a standard of care in patients
with SSNHL, the most recent clinical guideline of the
American Academy of Otolaryngology-Head and Neck Sur-
gery states HBO therapy as an adjuvant treatment option in the
management of SSNHL[3].
Although it is rare and mild in nature, side effects of HBO
therapy, particularly middle-ear barotrauma, in the pediatric
population is a major concern with limited data. Middle-ear
barotrauma may usually be avoided by comprehensive before-
treatment education, routine otoscopic examination prior to
each session and high vigilance. Any mass, foreign body or
exudate observed on otoscopy within the external ear canal may
hamper ear clearance and hence, should be removed before HBO
treatment. Otoscopic examination also provides evidence for
successful ear clearance, as the physician may witness the ear
Murat Salihoglu et al./Journal of Acute Disease 2016; 5(4): 340–342342drum while the patient performs ear clearing maneuvers. Fa-
miliarity with the normal structures of the ear and experience
with otoscopes is therefore, a pre-requisite for hyperbaric prac-
titioners. We interrupted HBO therapy in our patient due to ﬂu
like symptoms which hampered ear clearing and could put the
ear drum at risk for barotrauma. Treatment was continued and
terminated uneventfully.
HBO therapy may be considered in pediatric patients with
idiopathic SSNHL. However, we cannot rule out spontaneous
improvement of hearing in our patient. High vigilance for po-
tential side effects is a prerequisite for HBO treatment in pedi-
atric patients since they may fail to follow instructions properly.
Routine otoscopic examination of patients before each HBO
session is recommended to avoid middle ear barotrauma. Further
studies are required to conﬁrm the effectiveness and safety of
HBO therapy in children with SSNHL.
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